#Accelerationism CEO Albert Bourla wants to change all that.
Bourla is a Greek-born veterinarian who joined Pfizer’s local animal health division in 1993. He moved to the U.S. in 2001, and became Pfizer CEO in early 2019.
7 Clean Energy Stocks Trading Too Hot at the Moment
While most folks focused on Pfizer licensing the BioNTech (NASDAQ:BNTX) vaccine for manufacture, Bourla completed the spin-out of Pfizer’s Upjohn consumer business. It was combined with Mylan into Viatris (NASDAQ:VTRS). Since that deal was finalized, Viatris stock is down 16%, an endorsement of the strategy.